News
MAXONA Pharmaceuticals today announced that the company has submitted an Investigational New Drug (IND) Application to the ...
A psychiatrist explains why selective serotonin reuptake inhibitors (SSRIs) cause excess sweating in some people, and their ...
Research and development (R&D) expenses were $49.5 million for the second quarter of 2025, compared to $49.9 million for the comparable period in 2024. The decrease was primarily related to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results